Despite advances in the treatment of myocardial infarction (MI), the incidence of cardiogenic shock has remained at 7% to 10% during the last 25 years. Hospital mortality was about 90% in the 1970s; ...

The American Heart Association has created new registry will help researchers, clinicians and regulators to better understand the clinical symptoms of shock types, treatment patterns and outcomes. The ...

Johnson & Johnson MedTech today announced new data confirming the benefits of its Abiomed business' Impella CP system.

For patients with cardiogenic shock, the in-hospital mortality risk depends on the condition’s etiology—it’s substantially lower when it’s derived from acute decompensated heart failure (HF) than from ...

The “uneven playing field” related to demographics could be smoothed by stroke networks and standardized care.

Cardiogenic shock is the most common cause of death for patients hospitalized with acute myocardial infarction. The Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) ...

As a result of being less likely than men to receive lifesaving treatment when experiencing cardiogenic shock, women were significantly less likely to survive in the short and long term. Only half of ...

A Japanese registry study reveals how DanGer shock criteria predict survival in heart attack patients treated with Impella.

This Review explores contemporary circulatory support in profound postinfarction cardiogenic shock. Frequently, death is the only alternative to implantation of a blood pump, so prospective randomized ...

Memorial Regional Hospital has been recognized by Extracorporeal Life Support Organization (ELSO) as a "Designated Gold Level ...

The pumping of blood by the heart and its subsequent circulation around the body is referred to as the cardiovascular system. This system provides oxygen, and vital nutrients to the body's organs and ...